Transforming Growth Factor β Promotes Neuronal Cell Fate of Mouse Cortical and Hippocampal Progenitors In Vitro and In Vivo: Identification of Nedd9 as an Essential Signaling Component
暂无分享,去创建一个
[1] F. Pasquier,et al. Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease. , 2008, Human molecular genetics.
[2] Steven J. M. Jones,et al. Identification of a set of genes showing regionally enriched expression in the mouse brain , 2008, BMC Neuroscience.
[3] G. Sumara,et al. Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion. , 2008, Cell stem cell.
[4] M. Wegner,et al. Differential expression and dynamic changes of murine NEDD9 in progenitor cells of diverse tissues. , 2008, Gene expression patterns : GEP.
[5] M. Owen,et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. , 2008, Human molecular genetics.
[6] G. O'Neill,et al. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle , 2007, Cell Biochemistry and Biophysics.
[7] S. Iwata,et al. Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7 , 2007, Oncogene.
[8] E. Martí,et al. The TGFβ intracellular effector Smad3 regulates neuronal differentiation and cell fate specification in the developing spinal cord , 2007, Development.
[9] K. Krieglstein,et al. Transforming Growth Factor β Is Required for Differentiation of Mouse Mesencephalic Progenitors into Dopaminergic Neurons In Vitro and In Vivo: Ectopic Induction in Dorsal Mesencephalon , 2006, Stem cells.
[10] Michael W. Miller,et al. Transforming Growth Factor β1 Promotes Cell Cycle Exit through the Cyclin-Dependent Kinase Inhibitor p21 in the Developing Cerebral Cortex , 2005, The Journal of Neuroscience.
[11] S. Goderie,et al. Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. , 2005, Developmental biology.
[12] D. Stephan,et al. Gene and Protein Expression Changes in Human Trabecular Meshwork Cells Treated with Transforming Growth Factor-β , 2004 .
[13] Xiaohong Liu,et al. Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1 , 2004, BMC Cell Biology.
[14] S. Anderson,et al. Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation , 2004, Cell.
[15] E. Masliah,et al. Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.
[16] R. Kucherlapati,et al. Hierarchical model of gene regulation by transforming growth factor β , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Yoon,et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development , 2003, Development.
[18] Michael W. Miller. Expression of transforming growth factor‐β in developing rat cerebral cortex: Effects of prenatal exposure to ethanol , 2003, The Journal of comparative neurology.
[19] J. Massagué,et al. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. , 2003, Molecular cell.
[20] Hiroyuki Aburatani,et al. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells , 2002, Journal of cellular physiology.
[21] P. McKeown-Longo,et al. Regulation of HEF1 Expression and Phosphorylation by TGF-β1 and Cell Adhesion* , 2002, The Journal of Biological Chemistry.
[22] K. Krieglstein,et al. Tgfß2 –/– Tgfß3 –/– double knockout mice display severe midline fusion defects and early embryonic lethality , 2002, Anatomy and Embryology.
[23] J. Zavadil,et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. Verrecchia,et al. Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach* , 2001, The Journal of Biological Chemistry.
[25] K. Zuckerman,et al. Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis. , 2001, Journal of hematotherapy & stem cell research.
[26] E. Golemis,et al. A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1 , 2000, The EMBO journal.
[27] R. Oppenheim,et al. Reduction of endogenous transforming growth factors β prevents ontogenetic neuron death , 2000, Nature Neuroscience.
[28] J. Mallet,et al. Adenovirus-mediated over-expression of TGFbeta1 in the striatum decreases dopaminergic cell survival in embryonic nigral grafts. , 1999, Neuroreport.
[29] Y. Ouchi,et al. p57Kip2 Is Degraded through the Proteasome in Osteoblasts Stimulated to Proliferation by Transforming Growth Factor β1* , 1999, The Journal of Biological Chemistry.
[30] T. Takeshima,et al. EFFECTS OF TRANSFORMING GROWTH FACTORS ON DOPAMINERGIC NEURONS IN CULTURE , 1997, Neurochemistry International.
[31] L. Mucke,et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. , 1995, The American journal of pathology.
[32] C. Sherr,et al. D-type cyclins. , 1995, Trends in biochemical sciences.
[33] K. Unsicker,et al. TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. , 1995, The EMBO journal.
[34] D. Rifkin,et al. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. , 1994, Analytical biochemistry.
[35] Gary R. Grotendorst,et al. Connective Tissue Growth Factor , 1992, The Journal of dermatology.
[36] S. Kumar,et al. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. , 1992, Biochemical and biophysical research communications.
[37] H. Moses,et al. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development , 1991, The Journal of cell biology.
[38] M. Sporn,et al. Localization and actions of transforming growth factor-beta s in the embryonic nervous system. , 1991, Development.
[39] C. Miller,et al. Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. , 1991, Molecular and chemical neuropathology.
[40] F. Pasquier,et al. Association study of the NEDD 9 gene with the risk of developing Alzheimer ’ s and Parkinson ’ s disease , 2008 .
[41] Michael W. Miller,et al. Transforming growth factor beta 1 promotes cell cycle exit through the cyclin-dependent kinase inhibitor p21 in the developing cerebral cortex. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] P. Russell,et al. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. , 2004, Investigative ophthalmology & visual science.
[43] K. Unsicker,et al. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. , 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] K. Krieglstein,et al. Tgfbeta2 -/- Tgfbeta3 -/- double knockout mice display severe midline fusion defects and early embryonic lethality. , 2002, Anatomy and embryology.
[45] P. McKeown-Longo,et al. Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion. , 2002, The Journal of biological chemistry.
[46] Y. Ouchi,et al. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. , 1999, The Journal of biological chemistry.
[47] K. Unsicker,et al. Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity. , 1994, Neuroscience.
[48] J. Massagué,et al. Transforming growth factor-beta. , 1992, Cancer surveys.
[49] M. Sporn,et al. Transforming growth factor beta. , 1988, Advances in cancer research.
[50] P. C. Murphy,et al. Cerebral Cortex , 2017, Cerebral Cortex.
[51] A. Fisher,et al. Alzheimer’s and Parkinson’s Disease , 1986, Advances in Behavioral Biology.